Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$355M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$304M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$267M |
| 4 |
Gilead Sciences
GILD
|
+$239M |
| 5 |
Visa
V
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$388M |
| 2 |
Wells Fargo
WFC
|
+$370M |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$295M |
| 4 |
Alibaba
BABA
|
+$234M |
| 5 |
IBM
IBM
|
+$210M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.55% |
| 2 | Healthcare | 5.29% |
| 3 | Financials | 4.23% |
| 4 | Communication Services | 3.53% |
| 5 | Energy | 2.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARR
3926
Armour Residential REIT
ARR
$2.36B
| $157K | ﹤0.01% |
1,495
+1,391
| +1,338% | +$138K |
|
3927
Heron Therapeutics
HRTX
$61.3M
| $157K | ﹤0.01% |
8,706
+3,818
| +78% | +$75.3K |
|
|
NXRT
3928
NexPoint Residential Trust
NXRT
$631M
| $157K | ﹤0.01% |
12,009
-21
| -0.2% | -$255 |
|
3929
Agios Pharmaceuticals
AGIO
$1.95B
| $156K | ﹤0.01% |
3,893
+1,906
| +96% | +$81.5K |
|
3930
Natural Alternatives International
NAII
$13.7M
| $156K | ﹤0.01% |
+12,000
| New | +$122K |
|
3931
CALL
NNN REIT
NNN
$8.71B
| $156K | ﹤0.01% |
3,400
-1,300
| -28% | -$56.5K |
|
3932
PUT
NRG Energy
NRG
$25.2B
| $156K | ﹤0.01% |
12,000
-74,900
| -86% | -$856K |
|
|
ONIT
3933
CALL
Onity Group
ONIT
$328M
| $156K | ﹤0.01% |
5,207
-7,120
| -58% | -$489K |
|
|
SLCA
3934
CALL
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $156K | ﹤0.01% |
7,100
-40,000
| -85% | -$742K |
|
|
CLGX
3935
DELISTED
Corelogic, Inc.
CLGX
| $156K | ﹤0.01% |
4,570
-2,305
| -34% | -$78.3K |
|
|
SSRI
3936
CALL
DELISTED
Silver Standard Resources
SSRI
| $156K | ﹤0.01% |
31,200
-14,900
| -32% | -$78.7K |
|
3937
PUT
Brunswick
BC
$5.28B
| $155K | ﹤0.01% |
3,300
+1,300
| +65% | +$56.2K |
|
3938
Erie Indemnity
ERIE
$13.4B
| $155K | ﹤0.01% |
1,678
-1,767
| -51% | -$166K |
|
3939
PUT
Annaly Capital Management
NLY
$17.4B
| $155K | ﹤0.01% |
3,875
-14,150
| -79% | -$555K |
|
|
TLRD
3940
PUT
DELISTED
Tailored Brands, Inc.
TLRD
| $155K | ﹤0.01% |
+9,100
| New | +$140K |
|
|
ORBC
3941
DELISTED
ORBCOMM, Inc.
ORBC
| $155K | ﹤0.01% |
+15,545
| New | +$127K |
|
3942
America Movil
AMX
$70.3B
| $154K | ﹤0.01% |
10,258
-66,991
| -87% | -$926K |
|
3943
PUT
Nice
NICE
$5.95B
| $154K | ﹤0.01% |
+2,400
| New | +$144K |
|
3944
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.39B
| $154K | ﹤0.01% |
5,478
+2,778
| +103% | +$76.1K |
|
3945
ProShares Short 20+ Year Treasury ETF
TBF
$106M
| $154K | ﹤0.01% |
7,000
-604
| -8% | -$14K |
|
3946
CALL
World Kinect Corp
WKC
$1.88B
| $154K | ﹤0.01% |
+3,200
| New | +$137K |
|
3947
CALL
Banco Bradesco
BBD
$35B
| $153K | ﹤0.01% |
46,557
-9,779
| -17% | -$25.4K |
|
|
FISV
3948
CALL
Fiserv Inc
FISV
$28B
| $153K | ﹤0.01% |
3,000
+1,600
| +114% | +$75.9K |
|
3949
CALL
CVR Partners
UAN
$1.27B
| $153K | ﹤0.01% |
1,910
+1,870
| +4,675% | +$124K |
|
|
LM
3950
PUT
DELISTED
Legg Mason, Inc.
LM
| $153K | ﹤0.01% |
4,500
+800
| +22% | +$25.1K |
|
Similar funds
Barclays's Q1 2016 Portfolio in Review
As of Q1 2016, Barclays held 6,944 positions worth $65.6B, down 20% from $82.3B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays withdrew a net $15.2B in Q1 2016, closing 588 positions and reducing 2,924 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $295M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.5% of assets, up from 4.9% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR S&P Pharmaceuticals ETF worth $26M.
- Barclays's largest Q1 2016 buy was State Street SPDR S&P Pharmaceuticals ETF: 650,000 shares worth $26M.
- Barclays added most to KLA in Q1 2016, an estimated $355M increase.
- Barclays's biggest Q1 2016 reduction was Apple, cutting an estimated $388M.
- Barclays fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $295M.
- Barclays's ten largest holdings make up 29% of its $65.6B portfolio in Q1 2016.
- Barclays opened 766 new positions and closed 588 in Q1 2016.
- Barclays's portfolio value fell 20% quarter-over-quarter to $65.6B.
Based on Barclays's 13F filing for Q1 2016, filed 16 May 2016.